The Registry of Toxic Effects of Chemical Substances
Chromic acid, lead (2+) salt (1:1) |
UPDATE: May 2005 | MW: 323.19 | MF: CrO4•Pb |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
5 mg/L
|
BJCAAI 44,219,1981
|
cytogenetic analysis
|
human
lymphocyte
|
13 µmol/L
|
MUREAV 77,157,1980
|
cytogenetic analysis
|
human
other cell types
|
500 mg/L
|
BJCAAI 44,219,1981
|
DNA damage
|
hamster
ovary
|
1 µmol/L
|
MUREAV 280,129,1992
|
DNA damage
|
hamster
ovary
|
350 µmol/L/24 hour
|
TXAPA9 146,270,1997
|
DNA inhibition
|
hamster
kidney
|
150 mg/L
|
BJCAAI 44,219,1981
|
mutation in microorganisms
|
Escherichia coli
|
2 µmol/L (-enzymatic activation step)
|
MUREAV 91,33,1981
|
mutation in microorganisms
|
Salmonella typhimurium
|
200 µg/plate (+/-enzymatic activation step)
|
MUREAV 66,357,1979
|
micronucleus test
|
intraperitoneal | mouse
500 mg/kg
|
TJEMAO 146,373,1985
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
62,500 µg/L
|
MUREAV 66,357,1979
|
mutation in mammalian somatic cells
|
hamster
ovary
|
8 µmol/L
|
CRNGDP 13,2053,1992
|
morphological transform
|
hamster
kidney
|
156 mg/L
|
TECSDY 12,185,1986
|
morphological transform
|
hamster
embryo
|
40 µmol/L
|
CNREA8 39,193,1979
|
morphological transform
|
human
fibroblast
|
500 nmol/L
|
CNREA8 47,3815,1987
|
morphological transform
|
mouse
fibroblast
|
25 µmol/L
|
CNREA8 48,5280,1988
|
other mutation test systems
|
hamster
kidney
|
150 mg/L
|
BJCAAI 44,219,1981
|
other mutation test systems
|
human
other cell types
|
500 mg/L
|
BJCAAI 44,219,1981
|
sister chromatid exchange
|
hamster
ovary
|
100 µg/L
|
MUREAV 156,219,1985
|
sister chromatid exchange
|
human
lymphocyte
|
20 µmol/L
|
MUREAV 77,157,1980
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | rat
lowest published toxic dose: 324 mg/kg/39 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Tumorigenic: Tumors at site of application
CNREA8 36,1779,1976
|
subcutaneous | rat
lowest published toxic dose: 135 mg/kg
|
Tumorigenic: Neoplastic by RTECS criteria | Tumorigenic: Tumors at site of application
TUMOAB 57,213,1971
|
subcutaneous | rat
toxic dose : 135 mg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Tumorigenic: Tumors at site of application
PBPHAW 14,47,1978
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | guinea pig
lethal dose (75 percent kill): 156 mg/kg
|
N/R
|
85KYAH 11,852,1989
|
oral | mouse
lethal dose (50 percent kill): >12 gm/kg
|
N/R
|
OYYAA2 2,76,1968
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | dog
lowest published toxic dose: 11,250 mg/kg/90 day- continuous
|
Behavioral: Ataxia | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 37,160,1976
|
oral | rat
lowest published toxic dose: 108 gm/kg/90 day- continuous
|
Kidney, Ureter, and Bladder: Other changes | Blood: Other changes Blood: Changes in leukocyte (WBC) count
NTIS** OTS0571260
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.012 mg/m3
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Suspected Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Sufficient Evidence
|
IMEMDT 23,205,1980
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Sufficient Evidence
|
IMEMDT 49,49,1990
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 23,205,1980
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 49,49,1990
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 1
|
IMEMDT 49,49,1990
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
ceiling concentration 0.1 mg(CrO3)/m3
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
ceiling concentration 0.1 mg(CrO3)/m3
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
ceiling concentration 0.1 mg(CrO3)/m3
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
ceiling concentration 0.1 mg(CrO3)/m3
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.05 mg/m3, Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
Suspected Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.05 mg/m3, Carcinogen, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.02 mg(Cr)/m3, JAN1999
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.1 mg(Pb)/m3, JAN1999
|
Occupational Exposure Limit - FINLAND
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.05 mg(Cr)/m3, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.15 mg(Pb)/m3, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 0.01 mg(Cr)/m3, JAN1999
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 0.1 mg(Pb)/m3, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.1 mg(CrO3)/m3, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.05 mg(Pb)/m3, JAN1999
|
Occupational Exposure Limit - POLAND
|
time-weighted average 0.1 mg/m3, short term exposure limit 0.3 mg/m3, JAN1999
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 0.05 mg(Pb)/m3, JAN1999
|
Occupational Exposure Limit - SWEDEN
|
time-weighted average 0.02 mg(Cr)/m3, Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.05 mg(Cr)/m3, Carcinogen, JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.05 mg(Cr)/m3, Carcinogen, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Suspected Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Suspected Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CHROMIUM(VI)-air
|
Carcinogen; | 10 hour time-weighted average 0.001 mg(Cr)/m3
NIOSH* DHHS #92-100,1992
|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO LEAD, INORGANIC-air
|
10 hour time-weighted average <0.1 mg(Pb)/m3
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 81876; | Number of Industries 173; Total Number of Facilities 12,060; Number of Occupations 87; Total Number of Employees Exposed 131,959
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 81876; |
Number of Industries 33; Total Number of Facilities 1,628; Number of Occupations 28; Total Number of Employees Exposed 31,932; Total Number of Female Employees Exposed 8,639 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; Cell transform.-SA7/SHE
|
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used to make paint pigments for wood and metal
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 4, 1975/1976
|
NTP 11th Report on Carcinogens,2004:Known to be human carcinogen
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85KYAH
|
"Merck Index; an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ
07065, Merck & Co., Inc. 1989
|
BJCAAI
|
British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS,
UK) V.1- 1947-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
OYYAA2
|
Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1-
1967-
|
PBPHAW
|
Progress in Biochemical Pharmacology. (S. Karger AG, Postfach CH-4009 Basel, Switzerland)
V.1- 1965-
|
TECSDY
|
Toxicological and Environmental Chemistry. (Gordon & Breach Science Pub. Inc., 1 Park Ave.,
New York, NY 10016) V.3(3/4)- 1981-
|
TJEMAO
|
Tohoku Journal of Experimental Medicine. (Maruzen Co. Ltd., Export Dept., P.O. Box 5050,
Tokyo Int., 100-31 Tokyo, Japan) V.1- 1920-
|
TUMOAB
|
Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan, Italy) V.1- 1911-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
|